Abstract
Purpose
The aim of the study is to retrospectively evaluate and compare the therapeutic response of Radiofrequency (RF) and Microwave (MW) ablation therapy of hepatocellular carcinoma (HCC).
Materials and Methods
53 consecutive patients (42 males, 11 females; mean age 59 years, range: 40–68, SD: 4.2) underwent CT-guided percutaneous RF and MW ablation of 68 HCC liver lesions. The morphologic tumor response (number, location and size) was evaluated by magnetic resonance imaging. The follow-up protocol was 24 h post-ablation then within 3 monthly intervals post-ablation in the first year and 6 monthly intervals thereafter.
Results
Complete therapeutic response was noted in 84.4% (27/32) of lesions treated with RFA and in 88.9% (32/36) of lesions treated with MW ablation (P = 0.6). Complete response was achieved in all lesions ≤2.0 cm in diameter in both groups. There was no significant difference in rates of residual foci of HCC lesions between RF and MW ablation groups (P = 0.15, Log-rank test). Recurrence rate for 3, 6, 9, and 12 months in patients with HCC who underwent RF ablation compared with MW ablation were 6.3%, 3.1%, 3.1% versus 0%, 5.6%, 2.8%, and 2.8%. Progression-Free Survival rates for treated patients with RF ablation of 1, 2, and 3 years were 96.9%, 93.8%, and 90.6% and treated with MW ablation therapy were 97.2%, 94.5%, and 91.7, respectively (P = 0.98).
Conclusion
In conclusion, RF and MW ablation therapy showed no significant difference in the treatment of HCC regarding the complete response, rates of residual foci of untreated disease, and recurrence rate.
Similar content being viewed by others
References
Yau T, Chan P, Epstein R, Poon RT (2009) Management of advanced hepatocellular carcinoma in the era of targeted therapy. Liver Int 29(1):10–17
Adam A (2002) Interventional radiology in the treatment of hepatic metastases. Cancer Treat Rev 28(2):93–99
Yamagiwa K, Shiraki K, Yamakado K, et al. (2008) Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study. J Gastroenterol Hepatol 23(3):482–490
Shiina S, Tagawa K, Niwa Y, et al. (1993) Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR Am J Roentgenol 160:1023–1028
Kotoh K, Sakai H, Sakamoto S, et al. (1994) The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy. Am J Gastroenterol 89:194–198
Livraghi T, Giorgio A, Marin G, et al. (1995) Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 197:101–108
Rossi S, Stasi MD, Buscarini E, et al. (1996) Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 167:759–768
Solbiati L, Ierace T, Goldberg SN, et al. (1997) Percutaneous US-guided RF tissue ablation of liver metastasis: results of treatment and follow-up in 16 patients. Radiology 202:195–203
Livraghi T, Goldberg SN, Monti F, et al. (1997) Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases. Radiology 202:205–210
Morris-Stiff G, Gomez D, de Liguori Carino N, Prasad KR (2009) Surgical management of hepatocellular carcinoma: Is the jury still out? Surg Oncol 18(4):298–321
Song DS, Bae SH (2012) Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period. Clin Mol Hepatol 18:258–267
Shock SA, Meredith K, Warner TF, et al. (2004) Microwave ablation with loop antenna: in vivo porcine liver model. Radiology 231:143–149
Ruers TJM, de Jong KP, Ijzermans JNM (2005) Radiofrequency for the treatment of liver tumours. Dig Surg 22(4):245–253
Shibata T, Iimuro Y, Yamamoto Y, et al. (2002) Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 223(2):331–337
Lau WY, Lai ECH (2008) Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 7(3):237–257
Livraghi T, Goldberg SN, Lazzaroni S, et al. (1999) Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 210:655–661
Xu H-X, Xie X-Y, Lu M-D, Chen J-W, et al. (2004) Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation. Clin Radiol 59(1):53–61
Helmberger T, Holzknecht N, Schopf U, et al. (2001) Radiofrequency ablation of liver metastases. Technique and initial results. Radiologe 41:69–76
Lencioni R, Allgaier HP, Cioni D, et al. (2003) Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology 228:235–240
Lin SM, Lin CJ, Lin CC, et al. (2004) Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology 127:1714–1723
Shiina S, Teratani T, Obi S, et al. (2005) A randomized controlled trial of radiofrequency ablation versus ethanol injection for small hepatocellular carcinoma. Gastroenterology 129:122–130
Gillams AR, Lees WR (2004) Radio-frequency ablation of colorectal liver metastases in 67 patients. Eur Radiol 14:2261–2267
Jackobs TF, Hoffmann RT, Trumm C, et al. (2006) Radiofrequency ablation of colorectal liver metastases: mid-term results in 68 patients. Anticancer Res 26:671–680
Ballem Naveen, Berber Eren, Pitt Tracy, et al. (2008) Laparoscopic radiofrequency ablation of unresectable hepatocellular carcinoma: long-term follow-up. HPB (Oxford) 10(5):315–320
Tobinaga Shuichi, Nanashima Atsushi, Araki Masato, et al. (2009) Evaluation of local coagulation therapy with hepatectomy for liver metastases. Gan To Kagaku Ryoho 36(12):2042–2044
Yi HM, Zhang W, Ai X, Li KY, Deng YB (2014) Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma conforming to the Milan criteria: systemic review and meta-analysis. Int J Clin Exp Med 15:3150–3163
Conflict of interest
There are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Thomas J. Vogl and Nour-Eldin A. Nour-Eldin have contributed equally in this study. Dr. Nour-Eldin A. Nour-Eldin is the leader, guarantor and designer of the entire study group.
Rights and permissions
About this article
Cite this article
Vogl, T.J., Farshid, P., Naguib, N.N.N. et al. Ablation therapy of hepatocellular carcinoma: a comparative study between radiofrequency and microwave ablation. Abdom Imaging 40, 1829–1837 (2015). https://doi.org/10.1007/s00261-015-0355-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-015-0355-6